Enanta Pharmaceuticals (ENTA) Stock: Buy, Sell, or Hold?
ENTA - Enanta Pharmaceuticals, Inc
$11.64
0.02 (0.17%)
â˛
5d:
+4.86%
30d:
-3.0%
90d:
-8.56%
WAIT
LOW Confidence
Analysis Updated: Oct 23, 2026 12:00 AM ET
Earnings: Nov 16, 2026
22d
Get Alerted When ENTA Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
âšī¸ NEUTRAL: ENTA is fairly priced but lacks strong directional signals. Wait for clearer setup or better entry on dips.
âšī¸ NEUTRAL: ENTA is fairly priced but lacks strong directional signals. Wait for clearer setup or better entry on dips.
In-depth Analysis How we analyze
Valuation Analysis: ENTA is currently trading at $11.64, which is considered slightly low relative to its 30-day fair value range of $11.58 to $12.71.
Technical Outlook: Technically, ENTA is in a downtrend. Immediate support is located at $10.95, while resistance sits at $12.63.
Market Sentiment: ENTA scores 33/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $21.83 (+87.6%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, ENTA is in a downtrend. Immediate support is located at $10.95, while resistance sits at $12.63.
Market Sentiment: ENTA scores 33/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $21.83 (+87.6%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
SLIGHTLY LOW
Historical Trading Range
$11.58 -
$12.71
Company Quality Score
46/100
(HOLD)
Options IV Signal
55th percentile
(NORMAL)
Volume Confirmation
HIGH
Confidence Score
60.4%
Protect Your Profits
Holding ENTA? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Options fairly priced (IV 55th percentile)
- BEARISH: Weak technical setup (33/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 87.6% below Wall St target ($21.83)
- WARNING: Composite score 46/100 in the bottom quintile â this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$11.58 -
$12.71
Current vs Trading Range
SLIGHTLY LOW
Expected Move (7 Days)
Âą$2.39
(20.5%)
Support & Resistance Levels
Support Level
$10.95
Resistance Level
$12.64
Current Trend
Downtrend
Technical data as of
Oct 23, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-4.90
Wall Street Target
$21.83
(+87.6%)
Revenue Growth (YoY)
-21.6%
Earnings Growth (YoY)
-66.2%
Profit Margin
-96.9%
Share & Embed Analysis
Last updated: October 23, 2026 8:08 PM ET
Data refreshes hourly during market hours. Next update: 9:08 PM
Data refreshes hourly during market hours. Next update: 9:08 PM
đĨ Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is ENTA showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
SRRK
Scholar Rock Holding Corp |
STRONG BUY
18 analysts |
$70 | 72 BUY |
|
DNLI
Denali Therapeutics Inc |
STRONG BUY
20 analysts |
$36 | 56 HOLD |
|
WVE
Wave Life Sciences Ltd |
STRONG BUY
20 analysts |
$17 | 47 HOLD |
|
MIRM
Mirum Pharmaceuticals Inc |
STRONG BUY
14 analysts |
$153 | 59 HOLD |
|
ARWR
Arrowhead PharmaceuticalâĻ |
STRONG BUY
15 analysts |
$108 | 61 BUY |
Advanced ENTA Option Strategies
Professional options setups generated by AI based on today's ENTA price and gamma walls.
